Charles Brynelsen

CIK: 0001712459

Transaction Breakdown

Open Market Buys (P)4 (80.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (20.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

COCH

Envoy Medical, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

COCH
Envoy Medical, Inc.
Feb 12, 2026
Purchase(P)
Direct
1M shares at avg. $0.40$400K
COCH
Envoy Medical, Inc.
Dec 3, 2025
Award(A)
Stock Option (right to buy)
Direct
62.5K shares-
COCH
Envoy Medical, Inc.
May 27, 2025
Purchase(P)
Direct
35K shares at avg. $1.65$58K
COCH
Envoy Medical, Inc.
May 23, 2025
Purchase(P)
Direct
13K shares at avg. $1.64$21K
COCH
Envoy Medical, Inc.
May 22, 2025
Purchase(P)
Direct
2K shares at avg. $1.68$3K

		Type	Shares	Price		Ownership
Feb 12, 2026	COCH Envoy Medical, Inc.	Purchase(P)	1,000,000	$0.40	$400,000	Direct
Dec 3, 2025	COCH Envoy Medical, Inc.	Award(A) Stock Option (right to buy)	62,500	-	-	Direct
May 27, 2025	COCH Envoy Medical, Inc.	Purchase(P)	35,000	$1.65	$57,673	Direct
May 23, 2025	COCH Envoy Medical, Inc.	Purchase(P)	13,000	$1.64	$21,363	Direct
May 22, 2025	COCH Envoy Medical, Inc.	Purchase(P)	2,000	$1.68	$3,367	Direct

1-5 of 5 transactions

About BRYNELSEN CHARLES

BRYNELSEN CHARLES (SEC CIK 0001712459) files insider reports with the SEC as Director of Envoy Medical, Inc. (COCH).

Signal8 holds 3 ownership filings by BRYNELSEN CHARLES, all Form 4s, filed between May 27, 2025 and Feb 17, 2026. Those filings report 5 transactions, from May 22, 2025 to Feb 12, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on BRYNELSEN CHARLES's filings is in WHITE BEAR LAKE, MN.

Recent filings by BRYNELSEN CHARLES

Feb 12, 2026: Open-market purchase of COCH shares (Form 4, code P).
Dec 3, 2025: Grant or award of COCH derivative securities (Form 4, code A).
May 27, 2025: Open-market purchase of COCH shares (Form 4, code P).
May 23, 2025: Open-market purchase of COCH shares (Form 4, code P).
May 22, 2025: Open-market purchase of COCH shares (Form 4, code P).

Other insiders filing for Envoy Medical, Inc. (COCH)

Potashnick Robert, CAO & VP of Finance
Lucas Brent T., Chief Executive Officer
McKhann Chas, Director
Patel Mona Chetan, Director
Kantor Susan, Director
TAYLOR GLEN A, 10% Owner

How to read Form 4 transaction codes